{"id":6611,"date":"2026-11-11T19:27:58","date_gmt":"2026-11-11T13:57:58","guid":{"rendered":"https:\/\/werindia.com\/blog\/?p=6611"},"modified":"2026-11-11T19:28:01","modified_gmt":"2026-11-11T13:58:01","slug":"how-theon-pharmaceuticals-is-contributing-to-indias-growing-pharmaceutical-manufacturing-industry","status":"publish","type":"post","link":"https:\/\/werindia.com\/blog\/how-theon-pharmaceuticals-is-contributing-to-indias-growing-pharmaceutical-manufacturing-industry\/","title":{"rendered":"How Theon Pharmaceuticals Is Contributing to India’s Growing Pharmaceutical Manufacturing Industry"},"content":{"rendered":"\n

The Indian pharmaceutical market is growing at a rapid rate. This country is renowned as the “Pharmacy of the World” and is the global backbone of the generic drug supply.<\/p>\n\n\n\n

The Indian pharmaceutical sector is the 3rd largest<\/a> <\/strong>in the world by volume and holds the eleventh position by value. This sector comprises over 3,000 companies and 10,500 manufacturing facilities.<\/p>\n\n\n\n

Companies like Theon Pharmaceuticals are part of this progress. But how is the tablet manufacturing company<\/a> <\/mark><\/strong>contributing to India’s expanding pharmaceutical manufacturing landscape?<\/p>\n\n\n\n

Let’s take a closer look.<\/p>\n\n\n\n

1. Strengthening Pharmaceutical Manufacturing Infrastructure<\/mark><\/strong><\/h3>\n\n\n\n

The demand for medicines is increasing day by day. In this scenario, the pharmaceutical manufacturing industry is playing a crucial role.<\/p>\n\n\n\n

Theon Pharmaceuticals operates a well-developed manufacturing facility in Nalagarh, Himachal Pradesh.<\/p>\n\n\n\n

The facility has dedicated production blocks for general formulations, beta-lactam products, cephalosporins and dry powder injectables. This arrangement supports specialised manufacturing processes and helps maintain appropriate production conditions.<\/p>\n\n\n\n

The company’s installed annual manufacturing capacity includes:<\/p>\n\n\n\n

Pharmaceutical formulation<\/strong><\/td>Annual installed capacity<\/strong><\/td><\/tr>
Tablets<\/td>2,000 million<\/td><\/tr>
Capsules<\/td>1,000 million<\/td><\/tr>
Dry syrups<\/td>50 million<\/td><\/tr>
Dry powder injectables<\/td>100 million<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/a> <\/h3>\n\n\n\n

2. Maintaining Quality and Regulatory Standards<\/mark><\/strong><\/h3>\n\n\n\n

In pharmaceutical manufacturing, quality assurance plays an important role. Medicines need to fulfil certain guidelines and quality standards to ensure safety, consistency and efficacy.<\/p>\n\n\n\n

Theon Pharmaceuticals follows current Good Manufacturing Practices (cGMP) and maintains a quality management system aligned with ISO 9001:2015 requirements.<\/p>\n\n\n\n

Its quality control processes include chemical and microbiological testing. These checks help monitor product quality from raw material evaluation to finished product testing.<\/p>\n\n\n\n

The company also holds facility approvals from several international regulatory authorities. These include regulatory organisations in Kenya, Tanzania, Ethiopia, Uganda, and Sri Lanka.<\/p>\n\n\n\n

These approvals reflect the significance of maintaining manufacturing standards that meet the requirements of different pharmaceutical markets.<\/p>\n\n\n\n

3. Supporting Drug Development Through Research and Development<\/mark><\/strong><\/h3>\n\n\n\n

In the healthcare industry, existing formulations keep changing as per the guidelines. This makes research and development an important part, which helps address the changes.<\/p>\n\n\n\n

With in-depth research, pharmaceutical companies develop products with more advanced and better formulations.<\/p>\n\n\n\n

Theon Pharmaceuticals established its in-house R&D centre in 2016. The facility focuses on developing cost-effective and reliable pharmaceutical formulations.<\/p>\n\n\n\n

Its research activities cover several areas:<\/p>\n\n\n\n

R&D area<\/strong><\/td>Key focus<\/strong><\/td><\/tr>
Formulation development<\/td>Developing new pharmaceutical dosage forms<\/td><\/tr>
Modified-release technology<\/td>Developing controlled drug release formulations<\/td><\/tr>
Solubility enhancement<\/td>Improving drug solubility and bioavailability<\/td><\/tr>
Stability studies<\/td>Evaluating product stability under different conditions<\/td><\/tr>
Process validation<\/td>Supporting consistent manufacturing processes<\/td><\/tr>
Analytical development<\/td>Developing methods for product testing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

With a dedicated team and specialised research professionals, this company ensures that the product development stage meets all the right quality specifications.<\/p>\n\n\n\n

The R&D team also works with manufacturing and regulatory departments during scale-up and technology transfer. This helps move developed formulations towards commercial production.<\/p>\n\n\n\n

4. Expanding India’s Global Pharmaceutical Presence<\/mark><\/strong><\/h3>\n\n\n\n

The Indian pharmaceutical market expanded from USD 68.38 billion in 2025 to USD 75.89 billion<\/strong> in 2026 and is anticipated to grow to USD 174.67 billion by 2034, with a compound annual growth rate (CAGR) of 10.98% during the period from 2026 to 2034.<\/p>\n\n\n\n

India has established itself as a strong and growing supplier of affordable generic medicines. The rising demand of these medicines internationally has also created opportunities for Indian pharmaceutical manufacturers to expand in new markets.<\/p>\n\n\n\n

Theon Pharmaceuticals serves various international markets, including:<\/p>\n\n\n\n